These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20123936)

  • 1. Everyday and prospective memory deficits in ecstasy/polydrug users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    J Psychopharmacol; 2011 Apr; 25(4):453-64. PubMed ID: 20123936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ; McFie L; Fleetwood H; Robinson JA
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?
    Bedi G; Redman J
    J Psychopharmacol; 2008 Nov; 22(8):872-81. PubMed ID: 18208933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal and visual source memory deficits among ecstasy/polydrug users.
    Fisk JE; Gallagher DT; Hadjiefthyvoulou F; Montgomery C
    Hum Psychopharmacol; 2014 Mar; 29(2):172-82. PubMed ID: 24446108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reports of executive dysfunction in current ecstasy/polydrug Users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Cogn Behav Neurol; 2012 Sep; 25(3):128-38. PubMed ID: 22960437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Psychopharmacology (Berl); 2011 Jun; 215(4):761-74. PubMed ID: 21301817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
    Fisk JE; Montgomery C; Murphy PN
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC; Parrott AC; Turner JJ
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G; Redman J
    Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR; Kokkalis J
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.